PAYS vs TECH · P/E 43, rev $58.4M vs P/E 65, rev $1.22B
Paysign Inc (PAYS) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Paysign Inc (PAYS) is a software - infrastructure company listed on NASDAQ.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported PAYS revenue for 2024-12-31 was $58.4M. Net income was $3.8M. Revenue was up 23.5% from 2023-12-31 to 2024-12-31. PAYS currently screens at market cap $407.6M and trailing P/E 42.9.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
PAYS currently screens at market cap $407.6M and trailing P/E 42.9. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the PAYS and TECH stock pages for the full models.
Not investment advice.